Hims & Hers Health shares were headed for their biggest single-day plunge as Wall Street analysts questioned the telehealth ...

Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.

Copart's relentless compounding potential and long-term growth prospects make it a valuable investment. Click to find out why ...

Eli Lilly has cut the price for vials of its weight-loss drug Zepbound sold online and expanded the range of doses in an ...

Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s ...

The Outsourcing Facilities Association, a trade group representing compounders, filed a similar lawsuit in October last year ...

Hims & Hers said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo ...

根据美国证券交易委员会的Form 4文件显示，总部位于特拉华州的投资公司Focused Compounding Fund, LP近期大举增持Parks America, Inc. (OTC: PRKA )普通股。该基金以每股0.35美元的价格购入867,514股，总投资额约为303,629美元。目前该股票交易价格为0.41美元，根据 InvestingPro 的公允价值分析，当前估值偏高。

Eli Lilly announced a price reduction for its weight-loss drug Zepbound's vials by $50 or more, adapting to stiff competition ...

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...